Case Studies

The Clarity Bridge: How OncoAssign Translated Oncology Science into Human Storytelling

In the world of deep-tech and complex medical markets, founders often struggle with a translation problem: how to take a technically grounded product and explain its value to a payer who may not be the end-user. For Sushanth Shetty, the CEO of OncoAssign, the solution did not lie in more technical explanation, but in a more scientific approach to understanding the human drivers behind healthcare decisions.

“It was very methodical. There was a lot of science to it.”

Sushanth reflects on how the programme’s rigorous structure provided a framework for navigating an incredibly intricate landscape.  For OncoAssign, the “aha moment” arrived early as the programme’s methodology forced him to analyse his target audience’s needs in great detail.

This allowed him to focus on what truly drives decision-makers – in this case, oncologists – in a way that was both technically grounded and commercially resonant. “It was thoroughly helpful to understand what drives them and what success means to them,” Sushanth noted, highlighting how the programme helped him decode the often-conflicting motivations of the person who uses the tool versus the person who pays for it.

This clarity extended far beyond marketing, as it became a foundational tool for the entire business.  By applying a scientific lens to his messaging, he was able to move away from abstract claims and toward clear, succinct statements that highlighted OncoAssign’s competitive advantage.  This transformed how the company communicates its value to every stakeholder, from clinical partners to potential collaborators.

Most founders rely on the force of outreach rather than the surgical precision of market positioning.   Sushanth’s strategic depth was enhanced by the programme’s seamless integration of materials.  He highlighted the high caliber of the instructors and the “excellent structure” of the course, where detailed instructions and templates worked in tandem with presentations to guide him through complex strategic territory.

Today, the strategy for OncoAssign remains grounded in clarity. By moving away from a one-size-fits-all narrative and toward a scientifically positioned message, he has ensured that OncoAssign doesn’t just exist as a technical solution, but as a clear market leader.  For Sushanth, the WS&O experience was a masterclass in turning the technical excellence of OncoAssign into undeniable authority within the oncology space.

Image credit: Sushanth Shetty